FTXH Holdings
First Trust Nasdaq Pharmaceuticals ETF
1W: -2.3%
1M: -3.3%
3M: +4.7%
YTD: +23.0%
1Y: +37.8%
3Y: +64.2%
5Y: +68.4%
$40.73
-0.09 (-0.22%)
Weekly Expected Move ±2.1%
$39
$40
$41
$42
$42
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$1.0B
Holdings50
Top 10 Wt54.0%
Beta0.46
% Profitable57%
Coverage100%
Portfolio Valuation
P/E40.0
P/B9.7
P/S6.7
EV/EBITDA23.0
P/FCF27.8
PEG3.28
Profitability & Returns
Gross Margin74.3%
Net Margin16.1%
ROE24.0%
ROA7.7%
ROIC17.4%
Div Yield1.52%
Leverage & Liquidity
Debt/Equity1.16
Debt/Assets0.37
Net Debt/EBITDA1.9x
Interest Cov9.5x
Current Ratio1.27
Quick Ratio1.00
Growth (YoY)
Revenue+16.2%
Net Income+18.3%
EPS+19.7%
FCF+33.8%
EBITDA+22.2%
Rev CAGR 3Y+21.9%
Quality Scores
Piotroski F6.3
Altman Z8.87
IS Quality70.9
IS Overall61.4
IS Value43.6
Median P/E17.6
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 50 | 99.9% | -4.7 |
| Other | 1 | 0.1% | — |
Smart Money Overlap
1 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| PFE | Pfizer Inc. | 7.17% | 4 | Bullish | 3 | 2 | +5.6% |
Showing 50 of 51 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVie Inc. | ABBV | 7.30% | $77.6M | 296,538 | 74.0 | $464.3B | Healthcare |
| 2 | Pfizer Inc. | PFE | 7.17% | $76.2M | 2,671,763 | 36.7 | $158.4B | Healthcare |
| 3 | Eli Lilly and Company | LLY | 7.15% | $76.1M | 65,736 | 38.2 | $1.1T | Healthcare |
| 4 | Johnson & Johnson | JNJ | 7.12% | $75.7M | 286,020 | 29.6 | $617.0B | Healthcare |
| 5 | Merck & Co., Inc. | MRK | 7.03% | $74.8M | 514,608 | 114.5 | $356.4B | Healthcare |
| 6 | Viatris Inc. | VTRS | 3.84% | $40.8M | 2,302,798 | -48.9 | $20.5B | Healthcare |
| 7 | Biogen Inc. | BIIB | 3.73% | $39.6M | 175,488 | 38.7 | $32.5B | Healthcare |
| 8 | Gilead Sciences, Inc. | GILD | 3.64% | $38.7M | 259,802 | -55.7 | $179.5B | Healthcare |
| 9 | Amgen Inc. | AMGN | 3.51% | $37.3M | 88,442 | 24.8 | $217.5B | Healthcare |
| 10 | Incyte Corporation | INCY | 3.48% | $37.0M | 305,104 | 14.2 | $23.4B | Healthcare |
| 11 | Vertex Pharmaceuticals Incorporated | VRTX | 3.43% | $36.5M | 69,821 | 29.1 | $128.1B | Healthcare |
| 12 | Regeneron Pharmaceuticals, Inc. | REGN | 3.39% | $36.1M | 47,578 | 17.6 | $75.7B | Healthcare |
| 13 | United Therapeutics Corporation | UTHR | 3.37% | $35.8M | 66,128 | 17.9 | $23.0B | Healthcare |
| 14 | Bristol-Myers Squibb Company | BMY | 3.34% | $35.5M | 569,065 | 13.5 | $124.9B | Healthcare |
| 15 | Zoetis Inc. | ZTS | 3.24% | $34.4M | 493,116 | 11.5 | $29.2B | Healthcare |
| 16 | Jazz Pharmaceuticals Plc | JAZZ | 2.63% | $28.0M | 120,869 | 15.5 | $14.8B | Healthcare |
| 17 | Exelixis, Inc. | EXEL | 2.33% | $24.7M | 423,507 | 17.7 | $14.7B | Healthcare |
| 18 | Illumina, Inc. | ILMN | 2.26% | $24.0M | 87,809 | 50.5 | $41.3B | Healthcare |
| 19 | Halozyme Therapeutics, Inc. | HALO | 1.58% | $16.9M | 152,635 | 31.2 | $13.0B | Healthcare |
| 20 | Medpace Holdings, Inc. | MEDP | 1.54% | $16.3M | 26,194 | 34.5 | $16.7B | Healthcare |
| 21 | Alnylam Pharmaceuticals, Inc. | ALNY | 1.26% | $13.4M | 54,459 | 36.0 | $29.4B | Healthcare |
| 22 | BioMarin Pharmaceutical Inc. | BMRN | 1.26% | $13.4M | 222,648 | 150.5 | $11.1B | Healthcare |
| 23 | Neurocrine Biosciences, Inc. | NBIX | 1.20% | $12.7M | 89,832 | 20.3 | $14.4B | Healthcare |
| 24 | Elanco Animal Health Incorporated | ELAN | 1.15% | $12.2M | 545,369 | -54.0 | $11.1B | Healthcare |
| 25 | Charles River Laboratories International, Inc. | CRL | 1.02% | $10.9M | 36,780 | -60.0 | $14.0B | Healthcare |
| 26 | Iovance Biotherapeutics, Inc. | IOVA | 0.90% | $9.6M | 646,840 | -20.3 | $6.3B | Healthcare |
| 27 | 10X Genomics, Inc. (Class A) | TXG | 0.72% | $7.6M | 84,622 | -158.5 | $11.9B | Healthcare |
| 28 | Twist Bioscience Corporation | TWST | 0.69% | $7.3M | 38,019 | -85.0 | $11.7B | Healthcare |
| 29 | Moderna, Inc. | MRNA | 0.68% | $7.3M | 37,657 | -23.8 | $75.4B | Healthcare |
| 30 | Caris Life Sciences, Inc. | CAI | 0.60% | $6.4M | 207,324 | 76.1 | $8.0B | Healthcare |
| 31 | Adaptive Biotechnologies Corporation | ADPT | 0.58% | $6.1M | 212,065 | -69.6 | $4.5B | Healthcare |
| 32 | Amneal Pharmaceuticals, Inc. | AMRX | 0.57% | $6.1M | 302,501 | 40.8 | $6.5B | Healthcare |
| 33 | Guardant Health, Inc. | GH | 0.56% | $5.9M | 33,232 | -50.9 | $23.9B | Healthcare |
| 34 | Ligand Pharmaceuticals Inc. (Class B) | LGND | 0.55% | $5.8M | 18,602 | 30.3 | $6.1B | Healthcare |
| 35 | Tango Therapeutics, Inc. | TNGX | 0.54% | $5.8M | 231,378 | -27.3 | $3.8B | Healthcare |
| 36 | Roivant Sciences Ltd. | ROIV | 0.52% | $5.6M | 152,560 | -94.0 | $25.8B | Healthcare |
| 37 | Corcept Therapeutics Inc. | CORT | 0.51% | $5.4M | 46,622 | 223.5 | $12.6B | Healthcare |
| 38 | TG Therapeutics, Inc. | TGTX | 0.51% | $5.4M | 97,324 | 17.8 | $8.3B | Healthcare |
| 39 | Spyre Therapeutics, Inc. | SYRE | 0.50% | $5.3M | 59,160 | -47.8 | $8.1B | Healthcare |
| 40 | Kymera Therapeutics, Inc. | KYMR | 0.47% | $5.0M | 44,479 | -33.0 | $8.8B | Healthcare |
| 41 | Protagonist Therapeutics, Inc. | PTGX | 0.47% | $5.0M | 35,767 | 115.0 | $9.0B | Healthcare |
| 42 | Krystal Biotech, Inc. | KRYS | 0.46% | $4.9M | 14,705 | 39.0 | $9.5B | Healthcare |
| 43 | Oruka Therapeutics, Inc. | ORKA | 0.45% | $4.8M | 57,058 | -34.2 | $5.1B | Healthcare |
| 44 | Travere Therapeutics, Inc. | TVTX | 0.44% | $4.7M | 79,733 | -126.5 | $5.3B | Healthcare |
| 45 | Alkermes Plc | ALKS | 0.43% | $4.6M | 112,464 | 103.6 | $7.0B | Healthcare |
| 46 | Dianthus Therapeutics, Inc. | DNTH | 0.41% | $4.4M | 50,040 | -678.5 | $4.9B | Healthcare |
| 47 | Arrowhead Pharmaceuticals, Inc. | ARWR | 0.39% | $4.2M | 64,142 | -28.7 | $9.0B | Healthcare |
| 48 | Enliven Therapeutics Inc. | ELVN | 0.39% | $4.2M | 91,287 | -28.6 | $3.4B | Healthcare |
| 49 | ACADIA Pharmaceuticals Inc. | ACAD | 0.35% | $3.7M | 182,797 | 8.9 | $3.4B | Healthcare |
| 50 | Liquidia Technologies, Inc. | LQDA | 0.22% | $2.3M | 77,522 | 18.3 | $2.5B | Healthcare |